...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents
【24h】

Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents

机译:设计,合成和生物学评价一系列新型的1,3,4-恶二唑带有N-甲基-4-(三氟甲基)苯基吡唑部分作为细胞毒剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

On account of the reported anticancer activity of pyrazoles and oxadiazoles, we have designed and synthesized a novel combinatorial library of S-substituted-1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety and tested for in-vitro cytotoxic activity by MTT assay. Amongst the tested compounds, the compound 5e was the most promising anticancer agent with IC 50 value of 15.54 μM in MCF-7 cells, compared to Doxorubicin as standard drug. The newly synthesized compounds were characterized by NOE, IR, 1H NMR, 13C NMR and LC-MS analysis.
机译:考虑到已报道的吡唑和恶二唑的抗癌活性,我们设计并合成了带有N-甲基-4-(三氟甲基)苯基吡唑部分的S-取代-1,3,4-恶二唑的新型组合文库,并对其进行了测试。通过MTT测定的体外细胞毒性活性。在测试的化合物中,与阿霉素为标准药物相比,化合物5e是最有前途的抗癌剂,在MCF-7细胞中IC 50值为15.54μM。通过NOE,IR,1H NMR,13C NMR和LC-MS分析对新合成的化合物进行了表征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号